Reza Fathi
Director Técnico/Científico/I+D en REDHILL BIOPHARMA LTD. .
Fortuna: 74 913 $ al 30/04/2024
Cargos activos de Reza Fathi
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| REDHILL BIOPHARMA LTD. | Director Técnico/Científico/I+D | 01/05/2010 | - |
Historial de carrera de Reza Fathi
Antiguos cargos conocidos de Reza Fathi.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| XTL BIOPHARMACEUTICALS LTD. | Director Técnico/Científico/I+D | 01/01/2005 | - |
VivoQuest, Inc.
 VivoQuest, Inc. BiotechnologyHealth Technology VivoQuest, Inc. is engaged into the discovery and development of prescription drugs based on natural compounds derived small molecules. The in-house discovery research program in chemistry and biology aims at establishing and screening unique libraries of natural product-like compounds. VivoQuest's initial therapeutic area is the anti-viral field, including HIV and hepatitis C. VivoQuest is headquartered in Valley Cottage, NY. | Director de Operaciones | 01/01/2000 | - |
| Director Técnico/Científico/I+D | 01/01/2000 | - | |
| Harvard Medical School | Corporate Officer/Principal | 01/01/1998 | 01/01/2000 |
PharmaGenics, Inc.
 PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaGenics, Inc. develops therapeutic products for cancer. The American company was founded by Mike I. Sherman. PharmaGenics was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on June 18, 1997 for $112 million. | Corporate Officer/Principal | 01/01/1991 | 01/01/1998 |
Formación de Reza Fathi.
| Rutgers State University of New Jersey | Doctorate Degree |
| Texas Tech University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Israel | 3 |
| Francia | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| XTL BIOPHARMACEUTICALS LTD. | Health Technology |
| REDHILL BIOPHARMA LTD. | Health Technology |
| Empresas privadas | 2 |
|---|---|
PharmaGenics, Inc.
PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaGenics, Inc. develops therapeutic products for cancer. The American company was founded by Mike I. Sherman. PharmaGenics was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on June 18, 1997 for $112 million. | Commercial Services |
VivoQuest, Inc.
VivoQuest, Inc. BiotechnologyHealth Technology VivoQuest, Inc. is engaged into the discovery and development of prescription drugs based on natural compounds derived small molecules. The in-house discovery research program in chemistry and biology aims at establishing and screening unique libraries of natural product-like compounds. VivoQuest's initial therapeutic area is the anti-viral field, including HIV and hepatitis C. VivoQuest is headquartered in Valley Cottage, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Reza Fathi
- Experiencia
